Synergistic hepatoprotection mediated by Tangeretin in Naregamia alata: in vivo and in vitro evidences

Key Points

• Synergistic hepatoprotection was observed in both in vivo and in vitro models, highlighting tangeretin's effectiveness.
• In vitro experiments showed a marked reduction in liver enzyme levels, indicating improved liver function following treatment.
• Analysis included both in vivo and in vitro studies to assess the hepatic protective role of tangeretin derived from Naregamia alata.
• The findings suggest that tangeretin may offer a new approach to treat liver diseases, although clinical trials are needed.